Healthcare Providers and Health Systems
Patient volume is up. Referrals are strong, service lines are expanding, and patient activity looks healthy across the board.
Then finance is asked what actually happened to margin this quarter, and the honest answer takes longer to reach than it should. Billed revenue is climbing, but realised reimbursement, what's actually collected after contracts, denials, and payment variance, tells a less certain story. Cost-to-serve varies by service line in ways leadership may not yet be able to decompose consistently.
Whether volume growth is translating into real financial strength isn't something leadership can currently answer with confidence.
Patient activity and billed revenue are climbing, with no reliable decomposition of what that means for realised margin
The effect of payer mix shifts is understood in aggregate, but not always connected consistently to specific service lines, sites of care, or case types
Individual denials get worked and resolved, but the recurring causes behind them, by payer, service line, or coding pattern, often go untraced
Cost-to-serve is typically reported in aggregate, not decomposed by service line or case complexity, where the real margin variation usually lives
What's Actually Breaking
Billed revenue, contractual allowances, payer mix, and denials sit across the EHR, billing systems, and individual payer contracts. Assembling them into one view of what's actually realised, and why, is not always done consistently.
Cost is often tracked at the encounter or department level, without a clear view of how it varies by service line, case complexity, or site of care.
A denial gets worked and often overturned. Whether it recurs because of a specific payer's policy, a coding pattern, or a documentation gap is inconsistently tracked back to its source.
Shows billed revenue, collections, and denial volume clearly, but rarely decomposes margin movement into its actual drivers.
Request a Diagnostic ConversationAddresses the immediate case volume, but doesn't reduce the recurring causes generating denials in the first place.
Examine and reconcile each period's margin shift across patient activity, payer and contract mix, expected reimbursement, denials and payment variance, realised reimbursement, and cost-to-serve, using agreed rules rather than aggregate averages.
Where a step depends on an assumption rather than confirmed data, that's flagged explicitly, early enough for finance and revenue-cycle leaders to investigate before the pattern becomes materially larger.
ccountability for improving the weakest inputs is clarified before the next reporting cycle.
Reconcile reimbursement realisation consistently and flag denial patterns or cost-to-serve outliers by service line early enough for finance and revenue-cycle leaders to investigate before the pattern becomes materially larger.
Decide payer contracting strategy or how clinical resources get allocated across service lines. It can make the economics visible. Those decisions stay with leadership.
Examines financial performance across patient activity, payer and contract mix, expected versus realised reimbursement, denials, and service-line cost assumptions. Leadership leaves with a clearer view of what's actually driving margin, a flagged list of where the underlying data is weakest, and a prioritised view of what to address first.
Request a Diagnostic ConversationPatient volume growth means little if leadership can't trace what happened to the margin behind it.
If your business is growing but reporting, workflows, data, or execution are becoming harder to manage, Kelarix can help you diagnose where better systems can create real leverage.
